Potent Product Manufacturing in a Multi-Product Facility
Gain insight into how to properly assess and categorize HPAPIs to develop an appropriate containment strategy to manufacture them safely.
Leveraging Oral Solid Dose Technologies for the Development and Manufacturing of Potent Treatments
Industry experts as they delve into the driving forces that have created the recent surge in treatments for oncology and rare disease.
Modern Modelling Tools for Small Molecule Solid Dose Manufacturing
During the webinar, viewers will gain valuable insights through a series of case studies demonstrating how mathematical and computerized models were utilized to improve scale-up and efficiency in oral solid dose manufacturing.
Utilizing Phase-Appropriate CMC Strategies Throughout Clinical Development
Learn how to accelerate and de-risk clinical-stage drug programs by understanding phase-appropriate strategies that can give your molecule the best chance for success!
Introducing Catalent Xpress Pharmaceutics® – Facilitate Adaptive Trials and Accelerate Phase 1
An advanced development offering that integrates formulation expertise with on-demand Phase 1 clinical manufacturing, adaptive clinical testing and regulatory support, to help achieve flexible and efficient First-in-Human studies and expedited development.
Key Challenges and Opportunities in the Process Scale-Up of Oral Solid Dosage Forms
Summary: In this webinar, industrial and academic experts will share insights into faster drug product manufacturing in a large-scale setting, discuss emerging trends in OSD manufacturing and share strategies to ensure that quality is built into manufacturing processes.